Company chart and information is provided by TradingView based on 15-minute-delayed data.
Trinity Biotech PLC is in the business of development, manufacture, and marketing of clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita and others. Geographically, it has two segments namely the Americas and Rest of World of which it derives a majority of its revenues from the Americas segment.
| Website: | www.trinitybiotech.com |
| Email: | kevin.tansley@trinitybiotech.com |
| Main Phone: | +353 12769800 |
| Address: | IDA Business Park |
| Address 2: | Bray, Co. Wicklow |
| City / Town: | Dublin |
| Country: | IE |
| Exchange: | NGS |
| CEO: | Ronan O'Caoimh |
| Employees: | 579 |
| NAICS: | In-Vitro Diagnostic Substance Manufacturing(325413) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
